🫀 Coronary microvascular dysfunction is no longer a "hidden" diagnosis.

The new FLOW-CMD Registry published in The Lancet demonstrates that coronary microvascular dysfunction frequently coexists with obstructive coronary artery disease and significantly increases adverse cardiovascular outcomes.

Patients with CMD had: ⚠️ Higher cardiac death ⚠️ More repeat revascularization ⚠️ Increased heart failure hospitalization risk

This study reminds us that ischemic heart disease is more than epicardial stenosis alone. Coronary physiology — CFR, IMR, and FFR — may reshape future risk stratification and management.

🎙️ Featured on Dr RR Baliga's Podkast for the Kurious Doc: Where Curiosity Meets Clarity!

#Cardiology #CoronaryMicrovascularDysfunction #InterventionalCardiology #HeartFailure #MedicalPodcasts

🫀 Fascinating new study in the The New England Journal of Medicine explores "Stem-Cell–Derived Biologic Ventricular Assist Tissue (BioVAT)" for advanced heart failure. Investigators demonstrated that engineered heart-muscle patches derived from induced pluripotent stem cells increased ventricular wall thickness, modestly improved left ventricular ejection fraction, and enhanced quality of life in patients with severe heart failure.

This may represent an important step toward true cardiac remuscularization — moving beyond support devices toward biologic repair itself. 🔬❤️

#Cardiology #HeartFailure #StemCells #RegenerativeMedicine #BioVAT #MedicalPodcasts

🧬 Could a single infusion replace decades of lipid-lowering therapy?

The new NEJM study on VERVE-102 explores in vivo base editing of PCSK9 using CRISPR-inspired adenine base editing technology. In this phase 1 trial, a one-time infusion produced LDL cholesterol reductions up to 62% with durable effects extending beyond 1 year. ❤️

This may represent a major shift from chronic pharmacotherapy toward "once-and-done" genomic cardiovascular prevention.

The science, safety, clinical implications, and future of gene-editing cardiology on "Dr RR Baliga's Podkast for the Kurious Doc." 🎙️🧠

#Cardiology #CRISPR #PCSK9 #PrecisionMedicine #Genomics #LDL #NEJM #MedicalInnovation #PreventiveCardiology #medicalpodca

⚕️ Long before modern preventive medicine, Diocles of Carystus emphasized something remarkably familiar today: hygiene, exercise, balanced diet, sleep, and daily discipline.

A physician of 4th century BCE Greece, Diocles helped advance anatomy, surgery, nutrition, and holistic health. Some ancient sources even credit him with being among the first to use the term "anatomy." 🧠

His philosophy was simple yet profound: health depends on harmony between the body, mind, environment, and daily habits. 🌿

A timeless reminder that medicine is not only about treating disease—but about preserving healt

⚖️🚀 RETATRUTIDE may redefine obesity medicine.

In the Phase 3 TRIUMPH-1 trial, Lilly's triple agonist (GIP/GLP-1/glucagon) achieved an astonishing 28.3% average weight loss at 80 weeks, with some patients exceeding 30% weight reduction — territory once associated mainly with bariatric surgery. 📉

Even the 4 mg dose achieved nearly 20% weight loss with fewer discontinuations. Significant improvements were also seen in waist circumference, triglycerides, systolic BP, and hsCRP. ❤️

A fascinating glimpse into the future of cardiometabolic therapeutics.

🎙️ Dr RR Baliga's Podkast for the Kurious Doc

#Obesity #Retatrutide #GLP1 #Cardiology #Endocrinology #WeightLoss #Medical

🧪 New in JAMA: 4% tetrasodium EDTA significantly reduced ICU catheter complications in a multicenter randomized clinical trial.

Among 1,468 critically ill patients, EDTA locking solution lowered the composite risk of bloodstream infection, catheter occlusion requiring alteplase, and catheter removal due to occlusion. The strongest signal? Fewer catheter blockages and smoother ICU workflow. 💉🏥

A simple locking strategy with meaningful implications for patient safety, nursing workload, and catheter longevity.

#CriticalCare #ICU #Cardiology #InfectionPrevention #JAMA #MedicalEducation #MedicalPodcasts #CVAD #Research

🌙🧠 Fascinating new insights from Science reveal that sleep is far more than "rest." During non-rapid eye movement sleep, neuromodulators synchronize into ~50-second oscillatory rhythms that coordinate vascular pulsations, cerebrospinal fluid flow, and glymphatic clearance of amyloid-β and tau.

This elegant systems-level biology may explain why aging, psychiatric disease, stress, cardiovascular disease, and even common medications can increase dementia risk.

Sleep may be the brain's nightly cleansing symphony. 💤🌊

#Sleep #Neuroscience #Dementia #BrainHealth #GlymphaticSystem #MedicalPodcasts #Cardiology #Neurology #Alzheimers #Science

🧪❤️ Are preservatives in ultra-processed foods quietly increasing cardiovascular risk?

A major analysis from the NutriNet-Santé cohort published in the European Heart Journal followed >112,000 participants and linked several commonly used food additives with higher rates of hypertension and cardiovascular disease.

Notable signals emerged for sodium nitrite, potassium sorbate, sulphites, erythorbates, citric acid, and ascorbic acid additives.

This study reminds us that nutrition science is moving beyond calories and macronutrients toward the biological effects of industrial food processing itself. 🍔⚠️

Fresh foods may still be the best "cardiovascular preservative." 🫀

#Cardiology #Nutrition #PreventiveCardiology #HeartDisease #Hypertension #MedicalPodcast

🦠 The INTEGRAL-1 trial in The Lancet delivers exciting data for resistant urinary tract infections. Cefepime–nacubactam achieved both noninferiority AND superiority vs imipenem–cilastatin in complicated UTI and acute pyelonephritis.

⚡ Strong microbiological eradication, promising ESBL activity, and favorable safety profiles suggest an important future role in carbapenem-sparing strategies.

#UTI #Lancet #AntimicrobialResistance #ESBL #InfectiousDiseases #MedicalPodcasts

😴💊 Could a pill transform the treatment of obstructive sleep apnea?

The SynAIRgy Phase 3 trial of AD109 (aroxybutynin + atomoxetine) showed significant reductions in apnea–hypopnea index and hypoxic burden in patients unable to tolerate CPAP therapy. 🌙🫁

A once-nightly oral therapy targeting upper airway neuromuscular dysfunction may represent a new frontier in sleep medicine. Fascinating data with important implications for cardiovascular and metabolic health. 🫀📊

#SleepApnea #OSA #AD109 #SleepMedicine #RespiratoryMedicine #MedicalPodcasts #ClinicalTrials #PrecisionMedicine